Literature DB >> 11243498

Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

S M Dursun, S Devarajan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11243498     DOI： 10.1007/s002130000579

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  3 in total

1.  Citalopram plus reboxetine in treatment-resistant depression.

Authors:  S Devarajan; S M Dursun
Journal:  Can J Psychiatry       Date:  2000-06       Impact factor: 4.356

Review 2.  Treatment resistant depression: methodological overview and operational criteria.

Authors:  D Souery; J Amsterdam; C de Montigny; Y Lecrubier; S Montgomery; O Lipp; G Racagni; J Zohar; J Mendlewicz
Journal:  Eur Neuropsychopharmacol       Date:  1999-01       Impact factor: 4.600

3.  Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.

Authors:  R Whale; D J Quested; D Laver; P J Harrison; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2000-05       Impact factor: 4.530
  3 in total
  1 in total

1.  An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.

Authors:  Jeremy Barowsky; Thomas L Schwartz
Journal:  Psychiatry (Edgmont)       Date:  2006-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.